Garry E Menzel Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Garry E Menzel.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Garry E Menzel. Garry E Menzel is COO & Executive VP, Finance in Regulus Therapeutics Inc. ($RGLS) and Director in Stoke Therapeutics, Inc. ($STOK) and Director in Black Diamond Therapeutics, Inc. ($BDTX) and President & CEO in TCR2 THERAPEUTICS INC. ($TCRR) and President and CEO in TCR2 THERAPEUTICS INC. ($TCRR).
Latest Insider Trading Transactions of Garry E Menzel
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, BDTX, RGLS, STOK, TCRR
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 22 2021 | BDTX | Black Diamond Ther ... | Menzel Garry E | Director | Option Exercise | A | 12.55 | 15,000 | 188,250 | 15,000 | |
| Apr 23 2021 | BDTX | Black Diamond Ther ... | Menzel Garry E | Director | Option Exercise | A | 24.33 | 14,921 | 363,028 | 14,921 | |
| Apr 23 2021 | BDTX | Black Diamond Ther ... | Menzel Garry E | Director | Option Exercise | A | 24.33 | 14,921 | 363,028 | 14,921 | |
| Mar 08 2021 | TCRR | TCR2 THERAPEUTICS ... | Menzel Garry E | President and CEO | Grant | A | 16.12 | 686 | 11,061 | 4,085 | 3.4 K to 4.1 K (+20.18 %) |
| Mar 08 2021 | TCRR | TCR2 THERAPEUTICS ... | Menzel Garry E | President and CEO | Grant | A | 10.10 | 1,132 | 11,431 | 3,399 | 2.3 K to 3.4 K (+49.93 %) |
| Jan 27 2021 | STOK | Stoke Therapeutics ... | Menzel Garry E | Director | Option Exercise | A | 28.57 | 29,555 | 844,386 | 29,555 | |
| Dec 11 2020 | TCRR | TCR2 THERAPEUTICS ... | Menzel Garry E | President and CEO | Option Exercise | A | 31.38 | 245,000 | 7,688,100 | 245,000 | |
| Mar 27 2020 | TCRR | TCR2 THERAPEUTICS ... | Menzel Garry E | President & CEO | Grant | A | 10.10 | 1,287 | 12,999 | 2,267 | 980 to 2.3 K (+131.33 %) |
| Mar 27 2020 | TCRR | TCR2 THERAPEUTICS ... | Menzel Garry E | President & CEO | Grant | A | 12.75 | 980 | 12,495 | 980 | 0 to 980 |
| Feb 05 2020 | BDTX | Black Diamond Ther ... | Menzel Garry E | Director | Option Exercise | C | 0.00 | 156,297 | 0 | 0 | |
| Feb 05 2020 | BDTX | Black Diamond Ther ... | Menzel Garry E | Director | Buy | C | 0.00 | 51,825 | 0 | 51,825 | 0 to 51.8 K |
| Dec 20 2019 | TCRR | TCR2 THERAPEUTICS ... | Menzel Garry E | President and CEO | Option Exercise | A | 16.10 | 168,000 | 2,704,800 | 168,000 | |
| Apr 12 2019 | TCRR | TCR2 THERAPEUTICS ... | Menzel Garry E | President & CEO | Option Exercise | A | 16.11 | 486,106 | 7,831,168 | 486,106 | |
| Dec 13 2012 | RGLS | Regulus Therapeuti ... | Menzel Garry E | COO & Executive VP, ... | Option Exercise | A | 4.44 | 75,000 | 333,000 | 75,000 |
Page: 1